findmyKOL
Clinical trialNCT06535789RecruitingPhase 2/PHASE3Interventional

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

SponsorJaeb Center for Health ResearchEnrollment30Diabetes, GestationalGlucose Intolerance During PregnancyGlucose Metabolism DisordersPregnancy Complications
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Pregnant women aged 18-40 with gestational diabetes (GDM) will take part in this study. We want to see how two different insulin treatments affect their blood sugar after they eat. These women usually use a rapid-acting insulin analog (RAA) that's injected to control their blood sugar before and after meals. They will come to the clinic for two meal sessions. For the first meal, we will randomly decide if they will use the usual RAA insulin or a newer inhaled insulin called technosphere insulin (TI). They will use the other type of insulin for their second meal. After each meal, we will compare their blood sugar levels.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Sansum Diabetes Research Institute

    Santa Barbara, California, United States

    Kristin Castorino, MD
    Recruiting
  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado, United States

    Linda A Barbour, MD
    Recruiting
  • Icahn School of Medicine at Mount Sinai

    New York, New York, United States

    Carol Levy, MD
    Recruiting
  • Oregon Health and Science University

    Portland, Oregon, United States

    Amy Valent, DO
    Recruiting
  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Celeste Durnwald, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Inhaled Technosphere Insulin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2025
Primary completion
31 Jul 2025
Completion
31 Jul 2025
Last update posted
15 May 2025
Registered enrollment
30
Registry id
NCT06535789
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.